Geode Capital Management, LLC Vallon Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
$1.79 - $8.0 $6,673 - $29,824
3,728 Added 20.9%
21,569 $40,000
Q4 2021

Feb 11, 2022
SELL
$4.02 - $7.3 $25,297 - $45,938
-6,293 Reduced 26.08%
17,841 $106,000
Q3 2021

Nov 12, 2021
BUY
$3.85 - $9.68 $42,419 - $106,654
11,018 Added 84.0%
24,134 $175,000
Q2 2021

Aug 13, 2021
BUY
$3.66 - $5.83 $48,004 - $76,466
13,116 New
13,116 $71,000

About Vallon Pharmaceuticals, Inc.

VLON Quotes by TradingView
  • Ticker VLON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,512,800
  • Description
  • Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the ...
More about VLON
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email